Immunotherapy Drugs Market Scenario
Increased demand for personalized medicines, rising prevalence of cancer and autoimmune & infectious diseases and rising geriatric population are some of the major factors propelling the Immunotherapy Drugs market globally. Furthermore, growing demand for monoclonal antibodies and biosimilars is also one of the factor propelling the growth of Immunotherapy Drugs market. However, side-effects, and manufacturing complexities with immunotherapy drugs is one of the major factor expected to hamper the global growth of the market.
Immunotherapy Drugs Market Segmentation
The Immunotherapy Drugs market is segmented by Type, Therapeutic Area, End User and Geography. The types studied in immunotherapy drugs market are Monoclonal Antibodies, Checkpoint Inhibitors, Adult Vaccines (Preventive Vaccines and Therapeutic Vaccines), Interferons & Interleukins and Others. Furthermore, the therapeutic area comprises of Cancer (Malignant Cancers and Benign Cancers), Autoimmune & Inflammatory Diseases, Infectious Diseases and Others. In addition, Immunotherapy Drugs are used in various end user such as Hospitals, Clinics and Other End Users. Based on Geography, the Immunotherapy Drugs Market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.
Immunotherapy Drugs Market by Geography
Based on geography, the Immunotherapy Drugs market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the Asia Pacific region is anticipated to grow at a fastest growth rate during the forecast period owing to the increasing prevalence of cancer and other infectious diseases, universal health coverage for immunotherapy drugs in countries such as Japan and high number of cancer specialty care hospitals.
Immunotherapy Drugs Market Key Players
Some of the major players operating in the global Immunotherapy Drugs market includes Abbvie, Amgen, Astrazeneca, Bayer Ag, Biontech Se, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly And Company, F. Hoffmann-La Roche, Genmab, Gilead Sciences, Glaxosmithkline, Immatics Biotechnologies Gmbh, Johnson & Johnson, Merck & Co, Nbe Therapeutics, Novartis International Ag, Pfizer, Sanofi and Teva Pharmaceuticals.. Many Players in this market implement initiatives such as mergers and acquisitions, product developments, and geographic penetration to compete in the market.
Immunotherapy Drugs Market Report Key Benefits